DK1038522T3 - Antikonvulsive enantiomere aminosyrederivater - Google Patents

Antikonvulsive enantiomere aminosyrederivater

Info

Publication number
DK1038522T3
DK1038522T3 DK00109377T DK00109377T DK1038522T3 DK 1038522 T3 DK1038522 T3 DK 1038522T3 DK 00109377 T DK00109377 T DK 00109377T DK 00109377 T DK00109377 T DK 00109377T DK 1038522 T3 DK1038522 T3 DK 1038522T3
Authority
DK
Denmark
Prior art keywords
anticonvulsant
amino acid
acid derivatives
enantiomeric amino
animal
Prior art date
Application number
DK00109377T
Other languages
Danish (da)
English (en)
Inventor
Harold Kohn
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1038522(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of DK1038522T3 publication Critical patent/DK1038522T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00109377T 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater DK1038522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15

Publications (1)

Publication Number Publication Date
DK1038522T3 true DK1038522T3 (da) 2004-10-11

Family

ID=21760388

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00109377T DK1038522T3 (da) 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater
DK97916897T DK0888289T3 (da) 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97916897T DK0888289T3 (da) 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater

Country Status (12)

Country Link
EP (2) EP1038522B1 (enExample)
JP (1) JP3145414B2 (enExample)
AT (2) ATE202079T1 (enExample)
AU (1) AU718577B2 (enExample)
CA (1) CA2248317C (enExample)
DE (3) DE69729392T2 (enExample)
DK (2) DK1038522T3 (enExample)
ES (2) ES2218024T3 (enExample)
FR (1) FR09C0006I2 (enExample)
NL (1) NL300376I1 (enExample)
PT (2) PT1038522E (enExample)
WO (1) WO1997033861A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
US8440861B2 (en) 2009-08-06 2013-05-14 Medichem, S.A. Solid forms of an N-(phenylmethyl)propanamide derivative and processes of preparation
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
WO2011095995A1 (en) 2010-02-08 2011-08-11 Natco Pharma Limited A process for the preparation of lacosamide
US8907132B2 (en) 2010-02-09 2014-12-09 Msn Laboratories Private Limited Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
WO2012041986A1 (en) 2010-10-01 2012-04-05 Ucb Pharma Gmbh Process for the preparation of amino acid derivatives
EP2627639B1 (en) 2010-10-15 2021-12-22 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
ES2619403T3 (es) 2010-10-19 2017-06-26 Euticals Gmbh Proceso para producir lacosamida
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
EP2646001A2 (en) 2010-12-02 2013-10-09 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340902C (en) * 1985-02-15 2000-02-22 Harold L. Kohn Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
AU2539497A (en) 1997-10-01
ATE268169T1 (de) 2004-06-15
DE122009000010I2 (de) 2010-10-21
EP1038522A3 (en) 2003-01-15
NL300376I1 (nl) 2009-05-06
EP0888289A1 (en) 1999-01-07
JP2000505476A (ja) 2000-05-09
DE122009000010I1 (de) 2009-05-20
FR09C0006I2 (fr) 2009-12-18
ES2157567T3 (es) 2001-08-16
CA2248317A1 (en) 1997-09-18
DE69729392D1 (de) 2004-07-08
PT1038522E (pt) 2004-10-29
WO1997033861A1 (en) 1997-09-18
FR09C0006I1 (enExample) 2009-04-17
EP0888289B1 (en) 2001-06-13
EP1038522B1 (en) 2004-06-02
DK0888289T3 (da) 2001-09-03
JP3145414B2 (ja) 2001-03-12
EP1038522A2 (en) 2000-09-27
AU718577B2 (en) 2000-04-13
ATE202079T1 (de) 2001-06-15
ES2218024T3 (es) 2004-11-16
DE69705210D1 (de) 2001-07-19
CA2248317C (en) 2003-12-02
DE69705210T2 (de) 2001-09-20
DE69729392T2 (de) 2005-06-02
PT888289E (pt) 2001-09-28

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
EP1034783A4 (en) AMIDE DERIVATIVES
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
ATE194912T1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten
DK526087D0 (da) Antikonvulsive aminosyrederivater
DK498889D0 (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EA199900888A1 (ru) Противоревматические средства
EP0555479A4 (enExample)
FI965157A7 (fi) 2-((2,6-dikloorifenyyli)amiini)fenyyliasetoksietikkahapon uudet suolat orgaanisten emäksisten kationien kanssa
PL331407A1 (en) Method of treating bipolar disorders
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
BR9506763A (pt) Derivados de carbamoil metil uréia
ATE220544T1 (de) Neue verwendung von pyrazolopyridinverbindungen
AU5519590A (en) Amino acid derivative anticonvulsant